Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 207563

Expand all

DOCETAXEL (DOCETAXEL)
80MG/8ML (10MG/ML)
Marketing Status: Prescription

Active Ingredient: DOCETAXEL
Proprietary Name: DOCETAXEL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 80MG/8ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A207563
Product Number: 002
Approval Date: Aug 31, 2017
Applicant Holder Full Name: NOVAST LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

DOCETAXEL (DOCETAXEL)
160MG/16ML (10MG/ML)
Marketing Status: Prescription

Active Ingredient: DOCETAXEL
Proprietary Name: DOCETAXEL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 160MG/16ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A207563
Product Number: 003
Approval Date: Aug 31, 2017
Applicant Holder Full Name: NOVAST LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

DOCETAXEL (DOCETAXEL)
20MG/2ML (10MG/ML)
Marketing Status: Discontinued

Active Ingredient: DOCETAXEL
Proprietary Name: DOCETAXEL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20MG/2ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A207563
Product Number: 001
Approval Date: Aug 31, 2017
Applicant Holder Full Name: NOVAST LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information